Volume 1, Issue 1

Alzheimers Dementia Int. 2026;1(1):1005. | Letter to Editor | Open Access
Abstract | Fulltext PDF

Sex Differences in Treatment Effects of Lecanemab and Donanemab: A Bayesian Reanalysis of CLARITY AD and TRAILBLAZER-ALZ 2

Donald Berry

Share This Article:

---